Alzamend Neuro (ALZN) EPS (Basic) (2020 - 2026)
Alzamend Neuro's (ALZN) quarterly EPS (Basic) came in at -$0.86 in Q2 2026, up 76.39% year-over-year from -$0.49 in Q2 2025, and down 48.8% quarter-over-quarter from -$0.58 in Q1 2026.
Powered by 
Analysis
Alzamend Neuro (ALZN) EPS (Basic) (2020 - 2026) Analysis & Trends
Alzamend Neuro has disclosed EPS (Basic) across 7 years of filings, most recently posting -$0.86 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 76.39% year-over-year to -$0.86; the TTM figure through Apr 2026 stood at -$2.63 (up 76.79% YoY), while the FY2026 annual figure was -$2.63, up 76.79% from the prior year.
- EPS (Basic) came in at -$0.86 for Q2 2026 at Alzamend Neuro, down from -$0.58 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.3 in Q4 2025 to a low of -$74.49 in Q1 2023.
- Average EPS (Basic) over 5 years is -$25.45, with a median of -$22.65 recorded in 2024.
- Year-over-year, EPS (Basic) sank 151.83% in 2022 and soared 94.85% in 2025.
- Over 5 years, EPS (Basic) stood at -$43.07 in 2022, then rose by 7.48% to -$39.85 in 2023, then soared by 90.95% to -$3.61 in 2024, then jumped by 91.79% to -$0.3 in 2025, then sank by 190.54% to -$0.86 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.86 in Q2 2026, -$0.58 in Q1 2026, and -$0.3 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.66 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.06 |
| 10 | Alzamend Neuro | 5.54 Mn | 5.54 Mn | - | -0.86 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -0.86 |
| Jan 31, 2026 | -0.58 |
| Oct 31, 2025 | -0.30 |
| Jul 31, 2025 | -1.28 |
| Apr 30, 2025 | -3.64 |
| Jan 31, 2025 | -1.75 |
| Oct 31, 2024 | -3.61 |
| Jul 31, 2024 | -11.27 |
| Apr 30, 2024 | -11.33 |
| Jan 31, 2024 | -33.97 |
| Oct 31, 2023 | -39.85 |
| Jul 31, 2023 | -48.38 |
| Apr 30, 2023 | -45.76 |
| Jan 31, 2023 | -74.49 |
| Oct 31, 2022 | -43.07 |
| Jul 31, 2022 | -42.06 |
| Apr 30, 2022 | -58.69 |
| Jan 31, 2022 | -37.16 |
| Oct 31, 2021 | -52.00 |
| Jul 31, 2021 | -37.02 |